Literature DB >> 30090929

Association of Immunologic Markers With Survival in Upfront Resectable Pancreatic Cancer.

Ephraim S Tang1, Philippa H Newell1,2,3, Ronald F Wolf1,2, Paul Daniel Hansen1,2, Benjamin Cottam3, Carmen Ballesteros-Merino3, Michael J Gough3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30090929      PMCID: PMC6583701          DOI: 10.1001/jamasurg.2018.1757

Source DB:  PubMed          Journal:  JAMA Surg        ISSN: 2168-6254            Impact factor:   14.766


× No keyword cloud information.
  4 in total

Review 1.  Perioperative events influence cancer recurrence risk after surgery.

Authors:  Jonathan G Hiller; Nicholas J Perry; George Poulogiannis; Bernhard Riedel; Erica K Sloan
Journal:  Nat Rev Clin Oncol       Date:  2017-12-28       Impact factor: 66.675

Review 2.  Complex role for the immune system in initiation and progression of pancreatic cancer.

Authors:  Kristin S Inman; Amanda A Francis; Nicole R Murray
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

3.  Dynamics of the immune reaction to pancreatic cancer from inception to invasion.

Authors:  Carolyn E Clark; Sunil R Hingorani; Rosemarie Mick; Chelsea Combs; David A Tuveson; Robert H Vonderheide
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

4.  Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer.

Authors:  Julienne L Carstens; Pedro Correa de Sampaio; Dalu Yang; Souptik Barua; Huamin Wang; Arvind Rao; James P Allison; Valerie S LeBleu; Raghu Kalluri
Journal:  Nat Commun       Date:  2017-04-27       Impact factor: 14.919

  4 in total
  7 in total

1.  Dendritic Cell Maturation Defines Immunological Responsiveness of Tumors to Radiation Therapy.

Authors:  Tiffany C Blair; Shelly Bambina; Alejandro F Alice; Gwen F Kramer; Terry R Medler; Jason R Baird; Miranda L Broz; Garth W Tormoen; Victoria Troesch; Marka R Crittenden; Michael J Gough
Journal:  J Immunol       Date:  2020-04-27       Impact factor: 5.422

Review 2.  The Dynamic Entropy of Tumor Immune Infiltrates: The Impact of Recirculation, Antigen-Specific Interactions, and Retention on T Cells in Tumors.

Authors:  Tiffany C Blair; Alejandro F Alice; Lauren Zebertavage; Marka R Crittenden; Michael J Gough
Journal:  Front Oncol       Date:  2021-04-22       Impact factor: 6.244

3.  Transcriptional Upregulation of NLRC5 by Radiation Drives STING- and Interferon-Independent MHC-I Expression on Cancer Cells and T Cell Cytotoxicity.

Authors:  Lauren K Zebertavage; Alejandro Alice; Marka R Crittenden; Michael J Gough
Journal:  Sci Rep       Date:  2020-04-30       Impact factor: 4.379

4.  Orthotopic and Heterotopic Murine Models of Pancreatic Cancer Exhibit Different Immunological Microenvironments and Different Responses to Immunotherapy.

Authors:  Jin Wang; Xingchen Liu; Junsong Ji; Jianhua Luo; Yuanyu Zhao; Xiaonan Zhou; Jianming Zheng; Meng Guo; Yanfang Liu
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

5.  Explant Modeling of the Immune Environment of Head and Neck Cancer.

Authors:  Shay Sharon; Thomas Duhen; Shelly Bambina; Jason Baird; Rom Leidner; Bryan Bell; Nardy Casap; Marka Crittenden; Swetha Vasudevan; Maria Jubran; Nataly Kravchenko-Balasha; Michael Gough
Journal:  Front Oncol       Date:  2021-06-17       Impact factor: 6.244

Review 6.  T-Cell Immunity in Pancreatic Cancer.

Authors:  Reham Ajina; Louis M Weiner
Journal:  Pancreas       Date:  2020-09       Impact factor: 3.243

7.  Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.

Authors:  Andrew J Gunderson; Venkatesh Rajamanickam; Cynthia Bui; Brady Bernard; Joanna Pucilowska; Carmen Ballesteros-Merino; Mark Schmidt; Kayla McCarty; Michaela Philips; Brian Piening; Christopher Dubay; Terry Medler; Phillipa Newell; Paul Hansen; Eric Tran; Ephraim Tang; Carlo Bifulco; Marka Crittenden; Michael Gough; Kristina H Young
Journal:  Oncoimmunology       Date:  2021-03-17       Impact factor: 8.110

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.